<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>03700512925811</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512925811</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>02-IA-Phako</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:58:13.447Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512925828</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512925828</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-002</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:58:13.433Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512925941</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512925941</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-019</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:58:13.326Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512925958</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512925958</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-003</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:58:13.300Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512925965</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512925965</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-004</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:58:13.273Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512925972</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512925972</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-009</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:57:56.597Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512925989</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512925989</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-022</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:57:56.558Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512925996</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512925996</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-017</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:57:56.515Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512926641</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512926641</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1188</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:57:54.905Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393811758</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Katarakt Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66229662-06</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T06:17:07.238Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393811697</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Katarakt Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66230201-01</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T06:12:54.121Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393811673</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Katarakt Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66231881-02</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T06:08:52.352Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393811222</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>IOL-Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66220303-29</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T05:50:57.008Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393811062</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Katarakt Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66231913-03</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T05:45:03.508Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393811048</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Katarakt OP Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66231484-03</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T05:39:11.283Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393811000</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Katarakt Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66231790-03</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T05:33:14.250Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393810867</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Katarakt Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66231870-01</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T05:27:26.578Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393810607</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Katarakt-OP-Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66231763-03</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T05:21:09.288Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393809489</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Katarakt Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66231913-03</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T05:03:15.416Z</lastUpdated>
  </row>
  <row>
    <udiDi>03800238373306</udiDi>
    <basicUdiDi>380023TD03OPHIIA5C</basicUdiDi>
    <tradeName>Katarakt-OP-Set</tradeName>
    <deviceName>IVOM-OP-Set</deviceName>
    <manufacturerName>STS Medical Group AD</manufacturerName>
    <manufacturerSrn>BG-PR-000041814</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S78300104-01</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T04:56:03.306Z</lastUpdated>
  </row>
</eudamedExport>